AU2001268108A1 - Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders - Google Patents

Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders

Info

Publication number
AU2001268108A1
AU2001268108A1 AU2001268108A AU6810801A AU2001268108A1 AU 2001268108 A1 AU2001268108 A1 AU 2001268108A1 AU 2001268108 A AU2001268108 A AU 2001268108A AU 6810801 A AU6810801 A AU 6810801A AU 2001268108 A1 AU2001268108 A1 AU 2001268108A1
Authority
AU
Australia
Prior art keywords
interleukin
polypeptides
treatment
methods
nucleic acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001268108A
Inventor
Sudeepta Aggarwal
Jessica S. Foster
Audrey Goddard
Austin L. Gurney
Ellen M. Maruoka
William I. Wood
Ming-Hong Xie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=56290147&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2001268108(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from PCT/US2000/023328 external-priority patent/WO2001016318A2/en
Application filed by Genentech Inc filed Critical Genentech Inc
Priority claimed from PCT/US2001/017443 external-priority patent/WO2002016611A2/en
Publication of AU2001268108A1 publication Critical patent/AU2001268108A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1136—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against growth factors, growth regulators, cytokines, lymphokines or hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/11—Antisense
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/12—Type of nucleic acid catalytic nucleic acids, e.g. ribozymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/15—Nucleic acids forming more than 2 strands, e.g. TFOs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2001268108A 2000-08-24 2001-05-30 Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders Abandoned AU2001268108A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU75730/00 2000-08-24
PCT/US2000/023328 WO2001016318A2 (en) 1999-09-01 2000-08-24 Secreted and transmembrane polypeptides and nucleic acids encoding the same
PCT/US2001/017443 WO2002016611A2 (en) 2000-08-24 2001-05-30 Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders

Publications (1)

Publication Number Publication Date
AU2001268108A1 true AU2001268108A1 (en) 2002-03-04

Family

ID=56290147

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001268108A Abandoned AU2001268108A1 (en) 2000-08-24 2001-05-30 Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders

Country Status (6)

Country Link
EP (1) EP1311679B1 (en)
JP (1) JP3886899B2 (en)
AU (1) AU2001268108A1 (en)
CA (1) CA2419541C (en)
DK (1) DK1311679T3 (en)
ES (1) ES2316454T3 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2006082851A1 (en) * 2005-02-02 2008-06-26 国立大学法人 東京大学 Epiglycanin related mucin
WO2017049035A1 (en) 2015-09-17 2017-03-23 Amgen Inc. Prediction of clinical response to il23-antagonists using il23 pathway biomarkers
US20190317098A1 (en) * 2016-11-24 2019-10-17 Huvet Bio, Inc. Composition for diagnosis of diseases
KR102536314B1 (en) * 2018-05-23 2023-05-25 주식회사 휴벳바이오 Composition for diagnosing disease

Also Published As

Publication number Publication date
ES2316454T3 (en) 2009-04-16
EP1311679B1 (en) 2008-10-22
JP2004520811A (en) 2004-07-15
DK1311679T3 (en) 2009-02-23
CA2419541C (en) 2012-01-10
CA2419541A1 (en) 2002-02-28
EP1311679A2 (en) 2003-05-21
JP3886899B2 (en) 2007-02-28

Similar Documents

Publication Publication Date Title
WO2003023008A8 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
AU2002236300A1 (en) Novel protein, gene encoding the same and method of using the same
AU2001256373A1 (en) Syringe and method for the use thereof
AU3425700A (en) Non-ribosomal peptide synthetases, method for producing same and the use thereof
EP1487864A4 (en) Therapeutic polypeptides nucleic acids encoding same, and methods of use
AU2002356534A1 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
EP1446419A4 (en) Therapeutic polypeptides, nucleic acids encoding the same, and methods of use
AU2001264852A1 (en) Lactobacillusbeta -glucuronidase and dna encoding the same
EP1401858A4 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
EP1432726A4 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
AU2002334781A1 (en) Novel human proteins, polynucleotides encoding them and methods of using the same
AU2003217956A1 (en) Therapeutic polypeptides, nucleic acids encoding same and methods of use
WO2003040330A8 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
AU2001268108A1 (en) Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders
EP1532238A4 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
WO2003083039A8 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
EP1399537A4 (en) Therapeutic polypeptides, nucleic acids encoding same and methods of use
AU2002309646A1 (en) Novel human proteins, polynucleotides encoding them and methods of using the same
AU2001275959A1 (en) Method of treating the syndrome of type 2 diabetes in humans
AU2002241570A1 (en) Human proteins, polynucleotides encoding them and methods of using the same
WO2003023002A9 (en) Novel human proteins, polynucleotides encoding them and methods of using the same
AU2002365216A1 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
AU2002365189A8 (en) P85-alpha nucleic acids, polypeptides and related methods
EP1174503A4 (en) Novel proteins, gene encoding the same and method of utilization thereof
AU2001234150A1 (en) Novel protein and gene encoding the same